201 related articles for article (PubMed ID: 25591833)
1. Repurposing drugs in your medicine cabinet: untapped opportunities for cancer therapy?
Pantziarka P; Bouche G; Meheus L; Sukhatme V; Sukhatme VP
Future Oncol; 2015; 11(2):181-4. PubMed ID: 25591833
[No Abstract] [Full Text] [Related]
2. Repurposing Drugs in Oncology: Next Steps.
Verbaanderd C; Meheus L; Huys I; Pantziarka P
Trends Cancer; 2017 Aug; 3(8):543-546. PubMed ID: 28780930
[TBL] [Abstract][Full Text] [Related]
3. Repurposing drugs in oncology: From candidate selection to clinical adoption.
Pantziarka P; Verbaanderd C; Huys I; Bouche G; Meheus L
Semin Cancer Biol; 2021 Jan; 68():186-191. PubMed ID: 31982510
[TBL] [Abstract][Full Text] [Related]
4. Drug-repositioning opportunities for cancer therapy: novel molecular targets for known compounds.
Würth R; Thellung S; Bajetto A; Mazzanti M; Florio T; Barbieri F
Drug Discov Today; 2016 Jan; 21(1):190-199. PubMed ID: 26456577
[TBL] [Abstract][Full Text] [Related]
5. Repurposing of FDA-approved drugs against cancer - focus on metastasis.
Ozsvári B; Lamb R; Lisanti MP
Aging (Albany NY); 2016 Apr; 8(4):567-8. PubMed ID: 27038638
[No Abstract] [Full Text] [Related]
6. Drug Repurposing in Anticancer Reagent Development.
Chen PC; Liu X; Lin Y
Comb Chem High Throughput Screen; 2017; 20(5):395-402. PubMed ID: 28025934
[TBL] [Abstract][Full Text] [Related]
7. Off-label use of anti-cancer drugs in India: to be or not to be!
Gota V; Patial P
J Cancer Res Ther; 2011; 7(1):35-9. PubMed ID: 21546740
[TBL] [Abstract][Full Text] [Related]
8. Repurposing psychiatric drugs as anti-cancer agents.
Huang J; Zhao D; Liu Z; Liu F
Cancer Lett; 2018 Apr; 419():257-265. PubMed ID: 29414306
[TBL] [Abstract][Full Text] [Related]
9. Repurposing old drugs in oncology: Opportunities with clinical and regulatory challenges ahead.
Shah RR; Stonier PD
J Clin Pharm Ther; 2019 Feb; 44(1):6-22. PubMed ID: 30218625
[TBL] [Abstract][Full Text] [Related]
10. Repurposing Tecfidera for cancer.
Booth L; Malkin M; Dent P
Aging (Albany NY); 2016 Jul; 8(7):1289-90. PubMed ID: 27429364
[No Abstract] [Full Text] [Related]
11. Drug repurposing in cancer.
Sleire L; Førde HE; Netland IA; Leiss L; Skeie BS; Enger PØ
Pharmacol Res; 2017 Oct; 124():74-91. PubMed ID: 28712971
[TBL] [Abstract][Full Text] [Related]
12. Drug Repurposing in the Development of Anticancer Agents.
Olgen S; Kotra LP
Curr Med Chem; 2019; 26(28):5410-5427. PubMed ID: 30009698
[TBL] [Abstract][Full Text] [Related]
13. Turning liabilities into opportunities: Off-target based drug repurposing in cancer.
Palve V; Liao Y; Remsing Rix LL; Rix U
Semin Cancer Biol; 2021 Jan; 68():209-229. PubMed ID: 32044472
[TBL] [Abstract][Full Text] [Related]
14. Drug Selection in the Genomic Age: Application of the Coexpression Extrapolation Principle for Drug Repositioning in Cancer Therapy.
Gustafson DL; Fowles JS; Brown KC; Theodorescu D
Assay Drug Dev Technol; 2015 Dec; 13(10):623-7. PubMed ID: 26690765
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing for cancer therapy, easier said than done.
Gonzalez-Fierro A; Dueñas-González A
Semin Cancer Biol; 2021 Jan; 68():123-131. PubMed ID: 31877340
[TBL] [Abstract][Full Text] [Related]
16. [Off label drugs and pediatric hematology-oncology practices].
Le Guyader N; Pouliquen AL; Benoit G; Leverger G
Arch Pediatr; 2006 Sep; 13(9):1267-8. PubMed ID: 16814531
[No Abstract] [Full Text] [Related]
17. Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential target.
Islam S; Wang S; Bowden N; Martin J; Head R
Br J Clin Pharmacol; 2022 Jan; 88(1):64-74. PubMed ID: 34192364
[TBL] [Abstract][Full Text] [Related]
18. Unlocking hidden potential: advancements, approaches, and obstacles in repurposing drugs for cancer therapy.
Weth FR; Hoggarth GB; Weth AF; Paterson E; White MPJ; Tan ST; Peng L; Gray C
Br J Cancer; 2024 Mar; 130(5):703-715. PubMed ID: 38012383
[TBL] [Abstract][Full Text] [Related]
19. Can Drug Repurposing Accelerate Precision Oncology?
Schipper LJ; Zeverijn LJ; Garnett MJ; Voest EE
Cancer Discov; 2022 Jul; 12(7):1634-1641. PubMed ID: 35642948
[TBL] [Abstract][Full Text] [Related]
20. Selection of clinically relevant drug concentrations for in vitro studies of candidates drugs for cancer repurposing: a proposal.
Robles-Bañuelos B; Romo-Perez A; Dominguez-Gomez G; Chavez-Blanco A; Gonzalez-Fierro A; Duenas-Gonzalez A
Clin Transl Oncol; 2024 May; 26(5):1077-1088. PubMed ID: 38064014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
